Related Experiment Video

Updated: Jul 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

[New advances in clinical trials of cancer vaccines]

Feng Peng1, Yu-Quan Wei

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

AI Zheng = Aizheng = Chinese Journal of Cancer
|September 13, 2006
PubMed

Insights

Cancer vaccines, including peptide, DNA/RNA, and viral vector types, aim to eliminate tumor cells by activating the immune system. While promising, most cancer vaccines remain experimental due to ongoing safety and efficacy evaluations in clinical trials.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Context:

  • Cancer vaccines represent a diverse field utilizing various platforms like peptides, DNA/RNA, viral vectors, and dendritic cells to target malignancies.
  • The development of cancer vaccines involves rigorous preclinical animal studies followed by phased clinical trials to assess safety and efficacy.
  • Despite significant advancements, only a limited number of cancer vaccines have completed Phase III trials, highlighting the experimental nature of this therapeutic modality.

Purpose:

  • To review recent advancements in cancer vaccine clinical trials.
  • To discuss the current perspectives on the clinical application of novel cancer vaccines.
  • To provide an overview of the different types of cancer vaccine strategies under investigation.

Summary:

  • Cancer vaccines are designed to harness the immune system to recognize and eliminate cancer cells by presenting specific tumor antigens.
  • Various strategies, including peptide, DNA/RNA, viral vector, tumor cell, and pulsed dendritic cell vaccines, are under active investigation.
  • Clinical trials have demonstrated the potential of cancer vaccines to elicit potent immune responses and show promise across multiple cancer types, though many are still in experimental stages.

Impact:

  • This review highlights the ongoing progress and challenges in cancer vaccine development, offering insights into their future clinical utility.
  • Understanding the latest clinical trial findings is crucial for advancing cancer immunotherapy and patient care.
  • The successful translation of experimental cancer vaccines into approved therapies could revolutionize cancer treatment paradigms.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...